Live from the NIH registry
Studies recruiting near Brownsville right now
Top 25 of 67 recruiting studies, sorted by proximity — each links to its official registry page
cHAnging the Perceived Pain INtensity in divErSe Populations With Spinal Cord Injury
Spinal Cord Injuries
N/A
Interventional 40 participants sought
University of Texas - Rio Grande Valley — Harlingen, Texas (19.9 mi)
· Sponsor: University of Minnesota
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Arthritis, Psoriatic
Phase 3
Interventional 750 participants sought
Naiara Alvarez MD Integrative Rheumatology of South TX — Harlingen, Texas (19.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Eli Lilly and Company
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Texas Oncology - Harlingen, Medical Arts Pavillion — Harlingen, Texas (19.9 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 3,003 participants sought
AURORA-1 Clinical Site — Brownsville, Texas (7.1 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
South Texas Research Institute (STRI) - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Eccogene
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,200 participants sought
GSK Investigational Site — Brownsville, Texas (7.1 mi)
· Sponsor: GlaxoSmithKline
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Lupus Nephritis
Phase 4
Interventional 150 participants sought
Integrative Rheumatology of South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Aurinia Pharmaceuticals Inc.
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Phase 3
Interventional 1,000 participants sought
The University of Texas Rio Grande Valley — Harlingen, Texas (19.9 mi)
· Sponsor: Eli Lilly and Company
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Phase 3
Interventional 1,800 participants sought
Altimmune Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: Altimmune, Inc.
Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions
Acute Ischemic Stroke
N/A
Interventional 170 participants sought
Valley Baptist Medical Center - Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: RapidPulse, Inc
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Moderately to Severely Active Ulcerative Colitis
Phase 3
Interventional 350 participants sought
Cano Medical Center — Harlingen, Texas (19.9 mi)
· Sponsor: Hoffmann-La Roche
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Type 2 Diabetes
Phase 3
Interventional 600 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Brownsville, Texas (7.1 mi)
· Sponsor: Kailera
Study of Anxiety Free Experiences at the Dentist
Dental Phobia, Dental Anxiety in Children
N/A
Interventional 160 participants sought
University of Texas Rio Grande Valley — Brownsville, Texas (7.1 mi)
· Sponsor: University of Texas Rio Grande Valley
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Phase 2
Interventional 171 participants sought
Proactive RGV — Brownsville, Texas (7.1 mi)
· Sponsor: Uniquity One (UNI)
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Brownsville, Texas (7.1 mi)
· Sponsor: GlaxoSmithKline
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
Sciatica Acute, Lumbar Spinal Stenosis
Phase 4
Interventional 50 participants sought
Integrative Rheumatology of South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Primus Pharmaceuticals
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Cerebral Vasospasm, Aneurysmal Subarachnoid Hemorrhage (aSAH)
N/A
Observational 200 participants sought
Valley Baptist Medical Center- Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: Vesalio
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
South Texas Research Institute (STRI) - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Regeneron Pharmaceuticals
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Peripheral T Cell Lymphoma
Phase 3
Interventional 504 participants sought
Valley Cancer Associates — Harlingen, Texas (19.9 mi)
· Sponsor: Acrotech Biopharma Inc.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer, Metastatic Breast Cancer
Phase 3
Interventional 404 participants sought
Texas Oncology - Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: BriaCell Therapeutics Corporation
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
Endometrial Neoplasms, Endometrial Cancer
Phase 3
Interventional 600 participants sought
Texas Oncology - Central South — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: Hoffmann-La Roche